SANOFI CONS HEALTHC IND L

Sanofi Consumer Healthcare India Limited held its first Institutional Investor Meet on March 24, 2026, where management provided updates on the company's performance and strategic priorities. Managing Director Himanshu Bakshi highlighted the company's turnover of approximately ₹880 crore, with a Profit from Operations margin of 37% and a Return on Capital Employed (ROCE) of 62.5%. The company aims to reignite profitable growth through brand equity and increased investments in marketing. Bakshi noted the successful relaunch of previously recalled products and emphasized the importance of consumer education and engagement. The company reported a 21% increase in Revenue from Operations and a 33% rise in Profit After Tax (PAT) for the previous year. Management also discussed initiatives for social responsibility, including access to clean drinking water and environmental projects. The Q&A session addressed topics such as growth strategies, product pipelines, and market dynamics.

Management emphasized growth and successful initiatives during the investor meet.